1231006

Globela Pharma Pvt Ltd. — FEI 3010703501

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Surat (India)

Additional Details

Mutual Recognition Agreement (MRA)